Congenital Cardiac Anesthesia Society
A Section of the the Society for Pediatric Anesthesia

{“questions”:{“d7guh”:{“id”:”d7guh”,”mediaType”:”image”,”answerType”:”text”,”imageCredit”:””,”image”:””,”imageId”:””,”video”:””,”imagePlaceholder”:””,”imagePlaceholderId”:””,”title”:”Author: Meera Gangadharan, MD, FASA, FAAP – University of Texas at Houston \r\n\r\nA four-year-old male presents for computed tomography of the brain due to a history of seizures in setting of playing soccer. During inhalational induction, the patient becomes fearful and anxious with a heart rate of 190. Within seconds, there is an abrupt change in the ECG from normal sinus rhythm to a wide-complex, bidirectional ventricular tachycardia, which proves unresponsive to epinephrine. A baseline electrocardiogram was normal. What is the MOST likely diagnosis?”,”desc”:”EXPLANATION \r\nThe cardiac channelopathies are a heterogeneous group of arrhythmias that are associated with sudden cardiac death. The etiology is typically abnormal function of the sodium, potassium, and\/or calcium channel within the myocardial cell membrane. There is a strong genetic component and, therefore, obtaining a detailed family history and genetic testing is essential. Clinical features include syncope, seizures, or sudden cardiac death. \r\n\r\nCatecholaminergic polymorphic ventricular tachycardia (CPVT) is an inherited, congenital arrhythmia which usually manifests in children and young adults as dizziness, presyncope, syncope, seizures (secondary to syncope), and sudden cardiac death. It has an incidence of approximately one in 10,000. CPVT is characterized by a rapid polymorphic and bidirectional ventricular tachycardia (VT) occurring during physical exercise or emotional stress \u2013 see image below, used under Creatice Commons License. These patients are asymptomatic at rest and have normal resting electrocardiograms without structural cardiac abnormalities. \r\n\r\n \r\n\r\nElectrocardiogram during exercise stress testing demonstrates increasing frequency of ventricular arrhythmias, degrading from bigeminy to a typical bidirectional ventricular tachycardia. From Behere SP, Weindling SN. Catecholaminergic polymorphic ventricular tachycardia: An exciting new era. Ann Pediatr Cardiol <\/em>.2016;9(2):137-146. doi:10.4103\/0974-2069.180645. This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 3.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as the author is credited and the new creations are licensed under the identical terms.\r\nhttps:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC4867798\/ \r\nCPVT is caused by abnormal intracellular regulation of calcium in the cardiomyocyte resulting in ventricular ectopy, polymorphic couplets, ventricular fibrillation (VF), and ventricular tachycardia (VT) with a characteristic bidirectional morphology. Autosomal dominant mutations in the ryanodine receptor 2 (RYR2) gene account for 60-70% of cases, and autosomal recessive mutations in the calsequestrin 2 (CASQ2) gene account for an additional 10-15% of CPVT cases. Although most cases are familial, some individuals may present with de novo mutations in the absence of a family history of CPVT. \r\n\r\nThe five therapeutic options for the treatment of CPVT include the following: (1) lifestyle modifications; (2) beta-blockers; (3) implantable cardioverter-defibrillator (ICD); (4) flecainide; and (5) left cardiac sympathetic denervation. Life-style changes include avoiding triggers that cause increased sympathetic activity such as strenuous exercise and competitive sports. However, patients can partake in sports if they are asymptomatic and compliant on their medical regimens. Long-acting beta blockers, such as nadolol, are first line medical therapy. Flecanide can be effective in patients who are symptomatic despite maximal beta blocker therapy. Left cardiac sympathetic denervation (LCSD) is an effective option for patients who are still symptomatic despite maximal medical therapy. LCSD involves resection of the lower half of T1 and parts of the T2, T3 and T4 thoracic ganglia. Typically, ICD insertion is reserved for patients who are not fully responsive to medical therapy. However, ICD implantation may lead to several undesirable and potentially life-threatening complications and side effects, including the following: (1) inappropriate defibrillation; (2) catecholamine surge due to device discharge, which can potentially cause a \u201cstorm\u201d of ventricular tachycardia, and (3) complications related to the device such as pocket infection, lead fracture and displacement, endocarditis, vessel stenosis, and need for reimplantation of the ICD. In a systematic review of 53 studies describing 1,429 patients with a median age of 15 years and CPVT treated with ICD placement, 19.6% of patients experienced a storm which resulted in the death of 1.4% of patients.\r\n\r\nIt is important to have a high index of suspicion for CPVT in patients with a history of syncope with intense exertion, as epinephrine can be detrimental and cause further deterioration. Bellamy et al described three patients with the diagnosis of CPVT. Collectively, there were two episodes of ventricular tachycardia and one episode of ventricular fibrillation that were unresponsive to repeated doses of epinephrine but that resolved with administration of opiates. Two patients were rescued with extracorporeal membrane oxygenation and then underwent epinephrine challenge that resulted in polymorphic, bidirectional ventricular tachycardia, thereby confirming the diagnosis of CPVT. \r\n\r\nLong QT syndrome is characterized by the hallmark feature of prolongation of the QT interval on ECG, reflecting delayed myocardial repolarization, and is unlikely in this case as the patient had a previously normal ECG. Other hallmark features include polymorphic VT leading to syncope and sudden death. Brugada syndrome is characterized by abnormalities in the right ventricular outflow tract, which are responsible for characteristic ECG changes and the development of polymorphic VT\/VF. The key diagnostic feature of Brugada syndrome is the presence of a \u201ctype I Brugada ECG pattern \u201cin the right ventricular leads on the 12 lead ECG. This consists of a partial right bundle branch block, J point elevation, and coved ST segment elevation followed by a T wave inversion. Brugada syndrome is unlikely in this patient with a previously normal ECG. \r\n \r\n\r\n \r\nREFERENCE \r\nKim CW, Aronow WS, Dutta T, Frenkel D, Frishman WH. Catecholaminergic Polymorphic Ventricular Tachycardia. Cardiol Rev <\/em>. 2020;28(6):325-331. doi:10.1097\/CRD.0000000000000302 \r\nMellor GJ, Behr ER. Cardiac channelopathies: diagnosis and contemporary management [published online ahead of print, 2021 Feb 15]. Heart <\/em>.2021;heartjnl-2019-316026. doi:10.1136\/heartjnl-2019-316026 \r\nBellamy D, Nuthall G, Dalziel S, Skinner JR. Catecholaminergic Polymorphic Ventricular Tachycardia: The Cardiac Arrest Where Epinephrine Is Contraindicated. Pediatr Crit Care Med<\/em>. 2019;20(3):262-268. doi:10.1097\/PCC.0000000000001847 \r\nRoston TM, Jones K, Bos M et al. Implantable cardioverter-defibrillator use in catecholaminergic polymorphic ventricular tachycardia: A systematic review. Heart Rhythm. 2018; 15:1791-1799. https:\/\/doi.org\/10.1016\/j.hrthm.2018.06.046\r\n”,”hint”:””,”answers”:{“jfcoi”:{“id”:”jfcoi”,”image”:””,”imageId”:””,”title”:”A. Brugada syndrome”},”t6kbq”:{“id”:”t6kbq”,”image”:””,”imageId”:””,”title”:”B. Long QT syndrome”},”1y80o”:{“id”:”1y80o”,”image”:””,”imageId”:””,”title”:”C. Catecholaminergic polymorphic ventricular tachycardia\r\n\r\n”,”isCorrect”:”1″}}}}}

{“questions”:{“3b0vg”:{“id”:”3b0vg”,”mediaType”:”image”,”answerType”:”text”,”imageCredit”:””,”image”:””,”imageId”:””,”video”:””,”imagePlaceholder”:””,”imagePlaceholderId”:””,”title”:”Author: Meera Gangadharan, MD, FASA, FAAP – University of Texas at Houston \r\n\r\nA neonate presents with cyanosis, tachypnea, and poor oral intake. Vital signs are HR 180, BP 60\/40, RR 64, S_{p<\/sub>O2<\/sub> 75% in room air. A transthoracic echocardiogram demonstrates severe right atrial enlargement, severely depressed right ventricular function with moderate tricuspid regurgitation and leaflets in the normal location, and a severely thinned right ventricular free wall with bidirectional shunting across a patent foramen ovale. Left heart structures are normal. An electrocardiogram shows sinus tachycardia. What is the MOST likely diagnosis?”,”desc”:”EXPLANATION \r\nThis newborn has a rare cardiac condition called Uhl\u2019s anomaly, which is characterized by a very dilated, and poorly functioning right ventricle (RV). The free wall of the RV is dilated and paper-thin due to the absence of a myocardial muscle layer except for the cardiac apex where muscular trabeculations may be present. The pathogenesis is still debated but abnormal apoptosis of the RV myocardium is the most likely explanation as the myocardium is evident in early gestation. Biopsies are also notable for the absence of myocardial inflammation.\r\nFetal diagnosis can be challenging but has important implications for prognosis as Uhl\u2019s anomaly differs from other diagnoses that are similar. The papillary muscle of the tricuspid valve can be mistaken for the septal leaflet of the tricuspid valve, making it appear to be apically displaced. Magnetic resonance imaging (MRI) will typically demonstrate a pathognomonic absence of the myocardial muscle layer between the RV epicardium and endocardium. This is demonstrated in the illustration below. Patients usually present in the newborn period or infancy with signs of right heart failure, although there are case reports of adults with this condition. There may be tricuspid and pulmonary valve abnormalities as well. Left heart structures and the coronary arteries are typically normal. \r\nTreatment includes medical management with diuretics, digoxin, and beta blockers. Surgical options are generally determined by the specific anatomical substrate, but generally involve RV-exclusion procedures such as the Glenn, Fontan or one-and-a-half ventricle repairs which may include plication of excess right ventricular free wall. Cardiac transplantation may also be a treatment modality. \r\nThe two main diagnoses on the differential with Uhl\u2019s anomaly are arrhythmogenic right ventricular cardiomyopathy (ARVC, previously called arrhythmogenic right ventricular dysplasia) and Ebstein\u2019s anomaly. ARVC is characterized by arrhythmias and sudden cardiac death, usually in late childhood or young adulthood. Characteristic MRI appearances of ARVC are the presence of patches of fibrofatty infiltration between the layers of endocardium and epicardium. The left ventricle may also be involved in arrhythmogenic cardiomyopathy. Ebstein\u2019s anomaly is characterized by the apical displacement of the septal leaflet of the tricuspid valve with the sail-like appearance of the anterior leaflet. In contrast, the tricuspid valve leaflets insert at the true annulus of the tricuspid valve in Uhl\u2019s anomaly. The image below is an illustration of the typical cardiac magnetic resonance imaging in Uhl\u2019s anomaly. \r\n\r\n\r\n \r\nCardiac magnetic resonance, in steady-state free precession, four-chamber sequence showing marked right chamber dilatation. The tricuspid valve (TV) has normal positioning. A moderator band (MB) and a medium-volume pericardial effusion (PE) are visualized. LA<\/em>, Left atrium; LV<\/em>, left ventricle;RA<\/em>, right atrium;RV<\/em>, right ventricle. From Faria et al. https:\/\/doi.org\/10.1016\/j.case.2020.05.014. This is an open access article under the CC BY-NC-ND license (http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/). \r\n\r\n \r\nREFERENCES \r\nGerlis LM, Schmidt-Ott SC, Ho SY, Anderson RH. Dysplastic conditions of the right ventricular myocardium: Uhl’s anomaly vs arrhythmogenic right ventricular dysplasia. Br Heart J<\/em>. 1993;69(2):142-150. doi:10.1136\/hrt.69.2.142 \r\nMihos CG, Larrauri-Reyes M, Yucel E, Santana O. Clinical presentation, and echocardiographic characteristics of Uhl’s anomaly.Echocardiography<\/em>. 2017;34(2):299-302\r\nFaria B, von Hafe P, Ferreira FC, et al. Uhl’s Anomaly: 10 Years of Follow-Up of an Unoperated Patient. CASE (Phila)<\/em>. 2020;4(5):351-355. Published 2020 Jun 24. doi:10.1016\/j.case.2020.05.014 \r\nKalita JP, Dutta N, Awasthy N, et al. Surgical Options for Uhl’s Anomaly.World J Pediatr Congenit Heart Surg<\/em>. 2017;8(4):470-474. doi:10.1177\/2150135117710940 \r\nVaujois L, van Doesburg N, Raboisson MJ. Uhl’s anomaly: a difficult prenatal diagnosis. Cardiol Young<\/em>. 2015;25(3):580-583. doi:10.1017\/S1047951114000651\r\nCorrado D, Zorzi A, Cipriani A, et al. Evolving Diagnostic Criteria for Arrhythmogenic Cardiomyopathy. J Am Heart Assoc<\/em>. 2021;10(18): e021987.\r\n\r\n”,”hint”:””,”answers”:{“i1drd”:{“id”:”i1drd”,”image”:””,”imageId”:””,”title”:”A. Arrhythmogenic right ventricular cardiomyopathy “},”xsk3d”:{“id”:”xsk3d”,”image”:””,”imageId”:””,”title”:”B. Uhl\u2019s anomaly”,”isCorrect”:”1″},”dvhxa”:{“id”:”dvhxa”,”image”:””,”imageId”:””,”title”:”C. Ebstein\u2019s anomaly”}}}}}}

{“questions”:{“9i62x”:{“id”:”9i62x”,”mediaType”:”image”,”answerType”:”text”,”imageCredit”:””,”image”:”https:\/\/ccasociety.org\/wp-content\/uploads\/2023\/08\/Picture1-CCAS-832023.png”,”imageId”:”6703″,”video”:””,”imagePlaceholder”:””,”imagePlaceholderId”:””,”title”:”Author: Nicholas Houska, DO and Dustin Nash, MD – University of Colorado, Children\u2019s Hospital Colorado \r\n\r\nA 4-month-old infant has just undergone repair of Tetralogy of Fallot with a transannular patch, removal of right ventricular muscle bundles and ventricular septal defect (VSD) closure. Six hours postoperatively, the patient\u2019s heart rate gradually increases to 230 beats per minute with concurrent hypotension. The electrocardiogram (ECG) demonstrates a narrow complex tachycardia. An atrial electrogram is performed and illustrated below (From author\u2019s library). What is the MOST likely diagnosis?\r\n\r\n\r\n”,”desc”:”EXPLANATION \r\nJunctional ectopic tachycardia (JET) is an arrythmia most frequently seen in infants and children. It may be congenital in nature, but more commonly occurs postoperatively after cardiac surgery. JET originates from the area near the atrioventricular (AV) node and Bundle of His. It is most frequently associated with VSD closure, repair of Tetralogy of Fallot, and atrioventricular septal defect repair. Other risk factors for the development of JET include age less than 6 months, prolonged surgical time, prolonged cross clamp time, and the use of inotropes. The pathophysiology of postoperative JET is incompletely understood but is thought to be associated with trauma, stretch, and ischemia of the conduction system leading to the loss of cell membrane integrity. The etiology is likely multi-factorial but is ultimately related to increased sympathetic tone and automaticity. JET can be associated with significant morbidity and mortality. Additionally, it may be difficult to diagnose and treat. JET occurs with a frequency of 5-10% after congenital cardiac surgery. For these reasons, it is important for clinicians to have a high index of suspicion for JET and provide prompt diagnosis and treatment. \r\n\r\nJunctional ectopic tachycardia is typically a narrow complex tachycardia with ventriculo-atrial (VA) dissociation. The ventricular rate is typically irregular and higher than the atrial rate except in the less common instance of one to one (1:1) VA conduction. Onset is gradual with no initiating ectopic beat. Patients with JET have a heart rate greater than the 95th percentile for age, otherwise it is termed accelerated junctional rhythm. Diagnosis can be difficult on a standard surface ECG due to the difficulty in identifying atrial depolarization (P wave). In patients with atrial pacing leads, an atrial electrogram can be performed by connecting the atrial lead directly to one of the leads on a standard ECG. This allows identification of atrial depolarization in side by side comparison with ventricular depolarization in the other leads. The ECG below shows dissociation of ventricular depolarization (V) at a rate of 195 beats per minute (bpm) from atrial depolarization (A) at a rate of 170 bpm, which confirms the diagnosis of JET. Red squares are highlighting the association of QRS complexes on the standard ECG with the signals on the atrial electrogram. \r\n\r\nPostoperative JET is typically self-limited, but treatment may be indicated for hemodynamic instability. Treatment includes attenuating sympathetic stimulation by reducing inotrope dose, optimizing analgesia and sedation, and administration of dexmedetomidine. Correction of electrolytes and induction of mild hypothermia are also mainstays of treatment. Adenosine will not terminate JET but will cause AV dissociation when JET is difficult to identify. Amiodarone is the drug of choice for treatment. In refractory cases with hemodynamic instability, extracorporeal membrane oxygenation and\/or catheter ablation may be indicated. \r\n\t\r\n(Source: author\u2019s library)\r\n \r\nREFERENCES \r\nAlasti M, Mirzaee S, Machado C, et al. Junctional ectopic tachycardia (Jet). J Arrhythmia <\/em>.2020;36(5):837-844.\r\n\r\nKaltman JR, Madan N, Vetter VL, Rhodes LA. Arrhythmias and sudden cardiac death. In: Pediatric Cardiology<\/em>. Elsevier; 2006:171-194.\r\n\r\nSasikumar N, Kumar R, Balaji S. Diagnosis and management of junctional ectopic tachycardia in children. Ann Pediatr Card<\/em>. 2021;14(3):372.\r\n\r\nAshraf M, Goyal A. Junctional ectopic tachycardia. In: StatPearls<\/em>. StatPearls Publishing; 2023. Accessed July 21, 2023. https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK560851\/\r\n”,”hint”:””,”answers”:{“wud5a”:{“id”:”wud5a”,”image”:””,”imageId”:””,”title”:”A. Atrioventricular nodal reentrant tachycardia (AVNRT)”},”kh7ns”:{“id”:”kh7ns”,”image”:””,”imageId”:””,”title”:”B. Ventricular Tachycardia”},”ptlqh”:{“id”:”ptlqh”,”image”:””,”imageId”:””,”title”:”C. Junctional Ectopic Tachycardia”,”isCorrect”:”1″}}}}}

{“questions”:{“115eb”:{“id”:”115eb”,”mediaType”:”image”,”answerType”:”text”,”imageCredit”:””,”image”:””,”imageId”:””,”video”:””,”imagePlaceholder”:””,”imagePlaceholderId”:””,”title”:”Author: Nicholas Houska, DO and Raveendra Morchi, MD – University of Colorado, Children’s Hospital Colorado \r\n\r\nA 4-month-old male presents for surgical closure of a large ventricular septal defect (VSD) due to failure to thrive and feeding intolerance. Which of the following types of VSD is associated with the HIGHEST risk of injury to the conduction system and subsequent heart block during surgical closure?”,”desc”:”EXPLANATION \r\nSeptation of the ventricles occurs in the first trimester and is intimately related to development of the atrioventricular canals and the outflow tracts. The muscular septum forms from an infolding of ventricular muscle which develops to align with the conal septum of the ventricular outflow tracts. The final area of septation is the membranous septum which develops from the endocardial cushions. The development of the of the atrioventricular node, His-Purkinje system, and bundle branches anatomically coincide with the development of the ventricular septum. \r\n\r\nThere are multiple systems of nomenclature in common usage to describe and classify VSDs, which has led to significant confusion in the literature and clinical practice. To provide uniformity of language and improve communication, the International Society for Nomenclature of Pediatric and Congenital Heart Disease has proposed a classification system which has been accepted by the World Health Organization into the 11th iteration of the international classification of diseases. Under this classification, VSDs are divided into four major groups with descriptors added for the various subtypes within each group. The four groups are: perimembranous central, inlet, trabecular muscular, and outlet. Of these, the perimembranous central type is the most common, comprising greater than 80% of clinically significant VSDs. \r\n\r\nOne of the most serious complications after surgical closure of a ventricular septal defect (VSD) is complete heart block, having a significant impact on long term morbidity. Perimembranous VSDs are intimately associated with the conduction system at the inferoposterior margin, namely the AV node, Bundle of His, and right bundle branch, and are at the highest risk of surgically-induced heart block (see the image below \u2013 by R. Morchi, MD, used by permission). Careful surgical technique and suture placement in this area is essential to prevent damage to the conduction system and subsequent heart block. There is also risk of perioperative heart block after closure of an inlet VSD due to close proximity to the conduction system. Trabecular muscular and outlet VSDs are located in a more remote location from the major components of the conduction system and are much less likely to result in surgical heart block after surgical closure. With improvement in surgical techniques over the years, the current incidence of complete heart block after VSD closure is less than one percent.\r\n\r\n\t\r\n\r\n\r\n \r\n\r\n \r\nREFERENCES \r\nLopez L, Houyel L, Colan SD, et al. Classification of ventricular septal defects for the eleventh iteration of the international classification of diseases\u2014striving for consensus: a report from the international society for nomenclature of paediatric and congenital heart disease. The Annals of Thoracic Surgery <\/em>. 2018;106(5):1578-1589.\r\n\r\nGholampour-Dehaki M, Zareh A, Babaki S, Javadikasgari H. Conduction disorders in continuous versus interrupted suturing technique in ventricular septal defect surgical repair. Res Cardiovasc Med <\/em>. 2016;5(1).\r\n\r\nJonas RA. Vnetricular Septal Defect. In: Comprehensive Surgical Management of Congenital Heart Disease <\/em>.2nd ed. CRC Press; 2014. 331-346.\r\n\r\nAndersen H\u00d8, de Leval MR, Tsang VT, Elliott MJ, Anderson RH, Cook AC. Is complete heart block after surgical closure of ventricular septum defects still an issue? The Annals of Thoracic Surgery <\/em>. 2006;82(3):948-956.\r\n\r\nLamers WH, Moorman AFM. Cardiac septation: a late contribution of the embryonic primary myocardium to heart morphogenesis. Circulation Research <\/em>. 2002;91(2):93-103.\r\n”,”hint”:””,”answers”:{“21lqw”:{“id”:”21lqw”,”image”:””,”imageId”:””,”title”:”A. Perimembranous Central”,”isCorrect”:”1″},”6djzy”:{“id”:”6djzy”,”image”:””,”imageId”:””,”title”:”B. Trabecular Muscular”},”7yr2w”:{“id”:”7yr2w”,”image”:””,”imageId”:””,”title”:”C. Outlet”}}}}}

{“questions”:{“97cp5”:{“id”:”97cp5″,”mediaType”:”image”,”answerType”:”text”,”imageCredit”:””,”image”:””,”imageId”:””,”video”:””,”imagePlaceholder”:””,”imagePlaceholderId”:””,”title”:”Authors: Jeffrey C. Waldman MD, and Nicholas M. Houska, DO – Children\u2019s Hospital Colorado, University of Colorado School of Medicine, Aurora, CO \r\n\r\nThe duration of cardiopulmonary resuscitation (CPR) in a heart transplant donor is a known risk factor for decreased post-transplant survival. What DURATION of CPR performed on a heart transplant donor is associated with decreased post-transplant survival? “,”desc”:”EXPLANATION \r\nThe mortality of children awaiting heart transplantation is higher than any other solid organ transplant. Infants have the highest rate of waitlist mortality (25-30%), and children demonstrate a significantly higher risk of death compared to adults. This is related to the limited availability of donor organs and recipient factors such as age, weight, diagnosis, clinical status, and limited options for mechanical circulatory support. \r\n\r\nDonor characteristics that are associated with refusal for organ donation include gender, blood-type, Centers for Disease Control (CDC) \u201chigh risk\u201d criteria, reduced left ventricular ejection fraction (LVEF), and inotrope usage. Historically, there has been a decrease in the number of organs accepted for transplantation when a donor undergoes CPR. Among pediatric cardiac transplant physicians\/providers, there is also considerable variability in the evaluation of transplant donors, with no standardization of criteria for donor candidacy. \r\n\r\nA retrospective study by Kulshrestha et al from 2001 to 2021 using the United Network for Organ Sharing (UNOS) database compared the acceptance rate of donor hearts according to 1) whether the donor received CPR and 2) the duration of CPR. More than five thousand heart transplant recipients under the age of 18 years old were identified and survival analysis was performed to identify the duration of CPR which resulted in decreased post-transplant survival. A duration of CPR greater than 55 minutes in the donor resulted in a statistically significant decrease in post-transplant survival versus duration of CPR less than 55 minutes (mean survival 11.3 vs 10.2 years, p=0.03). During the study period, 51% of donors received CPR before organ procurement. Acceptance rate of the heart was lower when the donor received CPR as compared to no CPR (54 vs 66%, p less than 0.001) and decreased as the duration of CPR increased. Among the recipient cohort, 52% received a heart from a donor requiring CPR. With an inflection point in survival identified, the recipient cohort was divided into three groups: no donor CPR, CPR \u2264 55 minutes, and CPR greater than 55 minutes. Differences between the groups were identified and further analysis was performed to control for confounding variables. There was no difference in graft failure in recipients who received a heart transplant from a donor NOT requiring CPR as compared to recipients with a donor that had CPR \u2264 55 minutes. CPR duration greater than 55 minutes predicted worse post-transplant survival (HR 1.4 [1.03-1.90]) relative to no CPR, but CPR duration less than or equal to 55 minutes did not predict worsened survival (HR 1.02 [0.90-1.17]) relative to no CPR. Other significant variables affecting post-transplant survival include donor age, race of the recipient, renal dysfunction and dialysis in the recipient, extracorporeal membrane oxygenation in the recipient, and congenital heart disease in the recipient. \r\n\r\n \r\nREFERENCES \r\nAlmond CS, Thiagarajan RR, Piercey GE, et al. Waiting list mortality among children listed for heart transplantation in the United States. Circulation <\/em>. 2009;119:717-27.\r\n\r\n\r\nDipchand AI. Current state of pediatric cardi ac transplantation. Ann Cardiothorac Surg <\/em>. 2018;7:31-55.\r\n\r\nGodown J, Kirk R, Joong A, et al. Variability in donor selection among pediatric heart transplant providers: Results from an international survey. Pediatr Transplant <\/em>. 2019;23:e13417.\r\n\r\nKulshrestha K, Greenberg JW, Guzman-Gomez AM, et al. Up to an hour of donor resuscitation does not affect pediatric heart transplantation survival. Ann Thorac Surg <\/em>. Published online June 2023:S0003497523005696.\r\n”,”hint”:””,”answers”:{“mqpbo”:{“id”:”mqpbo”,”image”:””,”imageId”:””,”title”:”A.\t> 15 minutes”},”avdqu”:{“id”:”avdqu”,”image”:””,”imageId”:””,”title”:”B.\t> 35minutes”},”57ae6″:{“id”:”57ae6″,”image”:””,”imageId”:””,”title”:”C.\t> 55 minutes”,”isCorrect”:”1″}}}}}